Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a patent to a device for delivering high amplitude broadband mechanical pulses to treat a lesion present in a blood vessel.

Robocath has announced the successful completion of what it has described as the first coronary angioplasty in China assisted by its R-One robotic platform. The procedure took place at the 301 Hospital in Beijing on 24 November, performed by Yundai Chen.

Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems  due to complaints of filter breakage during retrieval.

Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcomes after successful transcatheter aortic valve implantation with a balloon-expandable or a self-expanding valve, suggest that there are comparable outcomes between the two devices.

First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve system (Jenavalve) in patients with severe aortic regurgitation show that the device is safe and efficient in high-risk patients, significantly improves New York Heart Association (NYHA) classification.

The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system for mitral chordal repair, tracking the first patient enrolled in the early feasibility study of the device, have been presented at PCR London Valves 2021 (21–23 November, London, UK and virtual).

The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system for mitral chordal repair, tracking the first patient enrolled in the early feasibility study of the device, have been presented at PCR London Valves 2021 (21–23 November, London, UK and virtual).

The Minneapolis Heart Institute Foundation (MHIF; Minneapolis, USA) has announced the publication of research showing improved patient outcomes and significantly decreased 30-day mortality in aortic dissectionpatients managed through a unique comprehensive care strategy designed by a team with multidisciplinary expertise.

New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standardise the management of these patients from the emergency room to the cath lab.

European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic has been published in the European Heart Journal.

European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic has been published in the European Heart Journal.

New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standardise the management of these patients from the emergency room to the cath lab.